NVIDIA Corporation
$213.66-$1.72 (-0.8%)
NVIDIA Corporation’s quoted price sits in the upper half of its reported 52-week range, 12.21% below the high.
OTC · DTRK · USD
Stock price, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
DATATRAK International, Inc.’s quoted price sits in the lower half of its reported 52-week range, 70.3% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow DATATRAK International, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
DATATRAK International, Inc. delivers advanced technology and comprehensive service offerings tailored for the clinical research industry. Its flagship offering, DATATRAK ONE Unified Experience, is an integrated clinical enterprise platform empowering clinical professionals and service providers to efficiently design, execute, and oversee clinical trials. This robust suite features specialized modules such as UX CTMS 360 for trial planning and administration, UX Trial to streamline the design-to-deployment workflow, UX EDC & Medical Coding for secure data capture and delivery, and UX Randomization and Trial Supply Management for automating patient assignment and logistics. Further components include UX Patient Data Capture, UX Safety, and UX Training, which facilitates user education and certification tracking. Additionally, DATATRAK provides Clinical Consulting Services, offering expert training, ongoing support, a dedicated learning center, Software-as-a-Service hosting, adherence to industry standards, and bespoke trial design assistance. The company serves a diverse clientele, including contract research organizations, pharmaceutical and biotechnology firms, and medical device companies engaged in clinical studies. Founded in 1991, DATATRAK International, Inc. is headquartered in Mayfield Heights, Ohio.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 03:34 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$213.66-$1.72 (-0.8%)
NVIDIA Corporation’s quoted price sits in the upper half of its reported 52-week range, 12.21% below the high.
$348.91+$5.08 (+1.48%)
Apple Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.8% below the high.
$530.14-$0.87 (-0.16%)
Microsoft Corporation’s quoted price sits in the upper half of its reported 52-week range, 3.81% below the high.
$345.00-$6.81 (-1.94%)
Broadcom Inc.’s quoted price sits in the lower half of its reported 52-week range, 30.3% below the high.
$310.34-$7.48 (-2.35%)
Veeva Systems Inc.’s quoted price sits in the upper half of its reported 52-week range, 4.8% below the high.
$677.56-$15.12 (-2.18%)
Medpace Holdings, Inc.’s quoted price sits in the upper half of its reported 52-week range, 2.36% below the high.
$11.20-$0.28 (-2.44%)
Certara, Inc.’s quoted price sits in the upper half of its reported 52-week range, 5.72% below the high.
$4.75-$0.25 (-5.0%)
Veradigm Inc.’s quoted price sits in the upper half of its reported 52-week range, 20.83% below the high.